Navigation Links
Building bridges between the clinic and the laboratory

Cambridge, UK, 04 August 2008 - Disease Models & Mechanisms (DMM) is the first journal to focus on translational research and the use of model organisms to advance human health. Published by the Company of Biologists, DMM is a highly anticipated biomedical research journal which officially launched its inaugural issue both in print and online today at

DMM focuses on human disease and the research necessary to develop treatments for illness. The field of translational medicine where basic science research is "translated" into treatments and cures for disease has been growing exponentially, particularly given the recent advances in genomics and life sciences, and shifts in global research funding. DMM aims to fill a niche in translational research by publishing articles about human disease and the model organisms used in biomedical research.

The special inaugural issue features editorial commentary, review articles, and research highlights on topics ranging from cancer detection, to understanding human diseases using flies or worms and the future impact of mouse genetics on humankind. Future issues will include primary research articles, and DMM continues to invite authors to submit articles which focus on human disease. Interviews and Podcasts focusing on areas of special interest will become regular features.

DMM's founders believe that the journal will provide a community forum for clinicians and scientists to discuss their findings and observations. DMM's Editor-in-Chief, Vivian Siegel, invites students, fellows, policymakers, clinicians, and scientists to "use the journal and its website to share resources and discoveries".

In addition to its publishing goals, the journal is committed to assisting early-career scientists by offering travelling fellowships to graduate students and postdoctoral fellows. Awards of up to US$5000/₤2500 are offered to facilitate collaborative visits to other laboratories worldwide. Fellowship application forms can be downloaded from the DMM website.

Disease Models & Mechanisms will publish 5 issues in 2008. Issue 1 is a special inaugural issue; issues 2/3 and 4/5 will be combined double issues. From 2009, DMM will be published every month (12 issues/year). Authors benefit from a free trial period for access to DMM, which will be available until at least spring 2009. DMM is a new addition to the international journals published by the Company of Biologists, a not-for-profit publisher based in Cambridge, UK.


Contact: Donna Perry
The Company of Biologists

Related biology news :

1. 1/3 of reef-building corals face extinction
2. NJIT architect professor advocates best-building practices for high wind regions
3. Manchester clears first hurdle in €170 million biobank building boom
4. Building on pyramids of trash
5. UCI awarded $27.2 million for new stem cell building
6. Scientists make chemical cousin of DNA for use as new nanotechnology building block
7. In Todays Economy, You Can Strengthen Your Company by Building Your Brand
8. International workshop to address capacity building for rainforest leaders
9. Building the future -- 21st century nano tools to repair the nervous system
10. Building disease-beating wheat
11. Building blocks of life formed on Mars
Post Your Comments:
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
(Date:10/29/2015)... , Oct. 29, 2015 Daon, a ... that it has released a new version of its ... in North America have already ... v4.0 also includes a FIDO UAF certified server ... already preparing to activate FIDO features. These customers include ...
(Date:10/29/2015)... 29, 2015 NXTD ) ... focused on the growing mobile commerce market and ... StackCommerce, a leading marketplace to discover and buy ... smart wallet on StackSocial for this holiday season. ... the "Company"), a biometric authentication company focused on ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... Md. , Nov. 25, 2015  PharmAthene, Inc. ... Directors has adopted a stockholder rights plan (Rights Plan) ... net operating loss carryforwards (NOLs) under Section 382 of ... --> PharmAthene,s use of its NOLs ... "ownership change" as defined in Section 382 of the ...
(Date:11/25/2015)... LOS ANGELES and HOLLISTON, Mass. ... Regenerative Technology, Inc. (Nasdaq: HART ), a biotechnology ... announced that CEO Jim McGorry will present ... Tuesday, December 1, 2015 at 2:30 p.m. PT. The ... (link below) for 30 days. Management will also be ...
(Date:11/25/2015)... ... November 25, 2015 , ... A ... Black Aerospace Professionals (OPBAP) has been formalized with the signing of a Memorandum ... met with OPBAP leaders Capt. Karl Minter and Capt. Albert Glenn Tuesday, November ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and Zachary ... in their initial angel funding process. Now, they are paying it forward to ... early stage investments in the microbiome space. In this, they join other ...
Breaking Biology Technology: